List of bibliographic references indexed by immune
Number of relevant bibliographic references: 17.
Ident. | Authors (with country if any) | Title |
---|
000164 (2021) |
Mohit Goyal [Oman] | SLE patients are not immune to covid-19: importance of sending the right message across. |
000394 (2021) |
Tajamul H. Mir | Immune Thrombotic Thrombocytopenic Purpura (iTTP) in a Patient with Suspected COVID-19: Hydroxychloroquine Culprit or Just a Happenstance? |
000441 (2021) |
Asokan Devarajan [États-Unis] ; Marmar Vaseghi [États-Unis] | Hydroxychloroquine can potentially interfere with immune function in COVID-19 patients: Mechanisms and insights. |
000742 (2021) |
Michael S. Abers [États-Unis] ; Ottavia M. Delmonte [États-Unis] ; Emily E. Ricotta [États-Unis] ; Jonathan Fintzi [États-Unis] ; Danielle L. Fink [États-Unis] ; Adriana A Almeida De Jesus [États-Unis] ; Kol A. Zarember [États-Unis] ; Sara Alehashemi [États-Unis] ; Vasileios Oikonomou [États-Unis] ; Jigar V. Desai [États-Unis] ; Scott W. Canna [États-Unis] ; Bita Shakoory [États-Unis] ; Kerry Dobbs [États-Unis] ; Luisa Imberti [Italie] ; Alessandra Sottini [Italie] ; Eugenia Quiros-Roldan [Italie] ; Francesco Castelli [Italie] ; Camillo Rossi [Italie] ; Duilio Brugnoni [Italie] ; Andrea Biondi [Italie] ; Laura Rachele Bettini [Italie] ; Mariella D'Angio' [Italie] ; Paolo Bonfanti [Italie] ; Riccardo Castagnoli ; Daniela Montagna [Italie] ; Amelia Licari ; Gian Luigi Marseglia ; Emily F. Gliniewicz [États-Unis] ; Elana Shaw [États-Unis] ; Dana E. Kahle [États-Unis] ; Andre T. Rastegar [États-Unis] ; Michael Stack [États-Unis] ; Katherine Myint-Hpu [États-Unis] ; Susan L. Levinson [États-Unis] ; Mark J. Dinubile [États-Unis] ; Daniel W. Chertow [États-Unis] ; Peter D. Burbelo [États-Unis] ; Jeffrey I. Cohen [États-Unis] ; Katherine R. Calvo [États-Unis] ; John S. Tsang [États-Unis] ; Helen C. Su [États-Unis] ; John I. Gallin [États-Unis] ; Douglas B. Kuhns [États-Unis] ; Raphaela Goldbach-Mansky [États-Unis] ; Michail S. Lionakis [États-Unis] ; Luigi D. Notarangelo [États-Unis] | An immune-based biomarker signature is associated with mortality in COVID-19 patients. |
000788 (2021) |
Chris R. Triggle [Qatar] ; Devendra Bansal [Qatar] ; Hong Ding [Qatar] ; Md Mazharul Islam [Qatar] ; Elmoubashar Abu Baker Abd Farag [Qatar] ; Hamad Abdel Hadi [Qatar] ; Ali A. Sultan [Qatar] | A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic. |
000B12 (2020) |
Jixin Zhong [République populaire de Chine] ; Jungen Tang [République populaire de Chine] ; Cong Ye [République populaire de Chine] ; Lingli Dong [République populaire de Chine] | The immunology of COVID-19: is immune modulation an option for treatment? |
000B40 (2020) |
Gricelis P. Martinez [Venezuela] ; Mercedes E. Zabaleta [Venezuela] ; Camilo Di Giulio [Venezuela] ; Jaime E. Charris [Venezuela] ; Michael R. Mijares [Venezuela] | The Role of Chloroquine and Hydroxychloroquine in Immune Regulation and Diseases. |
000B64 (2020) |
Serena Colafrancesco [Italie] ; Rossana Scrivo [Italie] ; Cristiana Barbati [Italie] ; Fabrizio Conti [Italie] ; Roberta Priori [Italie] | Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients. |
000C53 (2020) |
Gisela Canedo-Marroquín [Chili] ; Farides Saavedra [Chili] ; Catalina A. Andrade [Chili] ; Roslye V. Berrios [Chili] ; Linmar Rodríguez-Guilarte [Chili] ; María C. Opazo [Chili] ; Claudia A. Riedel [Chili] ; Alexis M. Kalergis [Chili] | SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments. |
000D18 (2020) |
Alexis Mathian [France] ; Zahir Amoura [France] | Response to: 'Exacerbation of immune thrombocytopaenia triggered by COVID-19 in patients with systemic lupus erythematosus' by Kondo et al. |
000D40 (2020) |
Taru Dube ; Amrito Ghosh ; Jibanananda Mishra ; Uday B. Kompella [États-Unis] ; Jiban Jyoti Panda [États-Unis] | Repurposed Drugs, Molecular Vaccines, Immune-Modulators, and Nanotherapeutics to Treat and Prevent COVID-19 Associated with SARS-CoV-2, a Deadly Nanovector. |
001100 (2020) |
Ana Gomides [Brésil] ; Gilda Ferreira [Brésil] ; Adriana Kakehasi [Brésil] ; Marcus Lacerda [Brésil] ; Cláudia Marques [Brésil] ; Licia Mota [Brésil] ; Eduardo Paiva [Brésil] ; Gecilmara Pileggi [Brésil] ; José Provenza [Brésil] ; Edgard Reis-Neto [Brésil] ; Vanderson Sampaio [Brésil] ; Ricardo Xavier [Brésil] ; Marcelo Pinheiro [Brésil] | Impact of Chronic Use of Antimalarials on SARS-CoV-2 Infection in Patients With Immune-Mediated Rheumatic Diseases: Protocol for a Multicentric Observational Cohort Study. |
001109 (2020) |
Fabrizio Cantini [Italie] ; Delia Goletti [Italie] ; Linda Petrone [Italie] ; Saied Najafi Fard [Italie] ; Laura Niccoli [Italie] ; Rosario Foti [Italie] | Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review. |
001110 (2020) |
Joana Vitte [France] ; Moïse Michel [France] ; Soraya Mezouar [France] ; Aïssatou Bailo Diallo [France] ; Asma Boumaza [France] ; Jean-Louis Mege [France] ; Benoit Desnues [France] | Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines. |
001238 (2020) |
Nils Rother [Pays-Bas] ; Cansu Yanginlar [Pays-Bas] ; Rik G H. Lindeboom [Pays-Bas] ; Siroon Bekkering [Pays-Bas] ; Mandy M T. Van Leent [États-Unis, Pays-Bas] ; Baranca Buijsers [Pays-Bas] ; Inge Jonkman [Pays-Bas] ; Mark De Graaf [Pays-Bas] ; Marijke Baltissen [Pays-Bas] ; Lieke A. Lamers [Pays-Bas] ; Niels P. Riksen [Pays-Bas] ; Zahi A. Fayad [États-Unis] ; Willem J M. Mulder [États-Unis, Pays-Bas] ; Luuk B. Hilbrands [Pays-Bas] ; Leo A B. Joosten [Pays-Bas] ; Mihai G. Netea [Pays-Bas, Allemagne] ; Michiel Vermeulen [Pays-Bas] ; Johan Van Der Vlag [Pays-Bas] ; Raphaël Duivenvoorden [Pays-Bas, États-Unis] | Hydroxychloroquine Inhibits the Trained Innate Immune Response to Interferons. |
001545 (2020) |
Peng Liu [France] ; Liwei Zhao [France] ; Gladys Ferrere [France] ; Carolina Alves-Costa-Silva [France] ; Pierre Ly [France] ; Qi Wu [France] ; Ai-Ling Tian [France] ; Lisa Derosa [France] ; Laurence Zitvogel [France] ; Oliver Kepp [France] ; Guido Kroemer [France, République populaire de Chine, Suède] | Combination treatments with hydroxychloroquine and azithromycin are compatible with the therapeutic induction of anticancer immune responses. |
001726 (2020) |
Abdurrahman Tufan [Turquie] ; Aslihan Avano Lu Güler [Turquie] ; Marco Matucci-Cerinic [Italie] | COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "immune"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i \
-Sk "immune" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= Title.i
|clé= immune
}}
| This area was generated with Dilib version V0.6.38. Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021 | |